VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Associate Director, Digital Transformation & Operational Execution Lead

Johnson & Johnson is a leader in healthcare innovation, focused on developing treatments and cures for complex diseases. The Associate Director, Digital Transformation & Operational Execution Lead will drive technology-enabled modernization within the Preclinical Sciences and Translational Safety group, leading the design and implementation of digital solutions to enhance operational excellence and decision-making.

Senior Director, Head, Strategy & Operations, Data Science and Digital Health

Associate Director, Digital Capabilities & Business Transformation

Associate Director Business Transformation & Operations

Director, Global Development Strategy + Operations

Associate Director, GMA Strategic Operations 

Sign up with Google

Sign in with Google